Cita APA

Castaño-Díez, S., Zugasti, I., Calvo, X., Schulz, F., Avendaño, A., Palomo Sanchis, L., . . . Lopez-Guerra, M. (2024). AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Citación estilo Chicago

Castaño-Díez, Sandra, Ines Zugasti, Xavier Calvo, Felicitas Schulz, Alejandro Avendaño, Laura Palomo Sanchis, HELENA POMARES, Jordi Vila Bou, y Monica Lopez-Guerra. AML Typical Mutations (CEBPA, FLT3, NPM1) Identify a High-risk Chronic Myelomonocytic Leukemia Independent of CPSS Molecular. 2024.

Cita MLA

Castaño-Díez, Sandra, et al. AML Typical Mutations (CEBPA, FLT3, NPM1) Identify a High-risk Chronic Myelomonocytic Leukemia Independent of CPSS Molecular. 2024.